Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)
Benitec Biopharma (BNTC) posted Other Non Operating Income of -$89000.0 for Q3 2025, up 29.37% sequentially from -$126000.0 in Q2 2025, and down 195.7% YoY from $93000.0 in Q3 2024.
Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Other Non Operating Income for 7 years, with the latest figure at -$89000.0 in Q3 2025.
- Quarterly Other Non Operating Income fell 195.7% year-over-year to -$89000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$215000.0 (up 12.96% YoY) and the FY2025 annual result came in at -$131000.0, up 35.78% from the prior year.
- Other Non Operating Income improved to -$89000.0 in Q3 2025 per BNTC's latest filing, from -$126000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $152000.0 in Q4 2023 and troughed at -$507000.0 in Q3 2022.
- A 5-year average of -$85411.8 and a median of -$80000.0 in 2023 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 380.0% in 2021, down 1500.0% in 2021.
- Over 5 years, Other Non Operating Income stood at $48000.0 in 2021, then climbed by 4.17% to $50000.0 in 2022, then jumped by 204.0% to $152000.0 in 2023, then tumbled by 126.32% to -$40000.0 in 2024, then slumped by 122.5% to -$89000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$89000.0, -$126000.0, and -$40000.0 for Q3 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -126,000.00 |
| Dec 31, 2024 | -40,000.00 |
| Sep 30, 2024 | 93,000.00 |
| Jun 30, 2024 | -182,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Sep 30, 2023 | -56,000.00 |
| Jun 30, 2023 | -80,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | -507,000.00 |
| Jun 30, 2022 | -50,000.00 |
| Mar 31, 2022 | -29,000.00 |
| Dec 31, 2021 | 48,000.00 |
| Sep 30, 2021 | -240,000.00 |
| Jun 30, 2021 | -166,000.00 |
| Mar 31, 2021 | -112,000.00 |
| Dec 31, 2020 | 10,000.00 |
| Sep 30, 2020 | -54,000.00 |
| Jun 30, 2020 | 30,000.00 |